<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02152085</url>
  </required_header>
  <id_info>
    <org_study_id>13-0720</org_study_id>
    <secondary_id>R03HD079508</secondary_id>
    <nct_id>NCT02152085</nct_id>
  </id_info>
  <brief_title>Neuromuscular Electrical Stimulation and Mobility in Multiple Sclerosis</brief_title>
  <official_title>Neuromuscular Electrical Stimulation and Mobility in Multiple Sclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Boulder</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Colorado, Boulder</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the capacity of a 6-week treatment with&#xD;
      neuromuscular electrical stimulation to improve walking in individuals whose mobility has&#xD;
      been compromised by multiple sclerosis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will be randomly assigned to one of two study arms. Those in one arm will&#xD;
      receive a treatment with narrow stimulus pulses (0.4 ms) and those in the other arm will&#xD;
      receive wide stimulus pulses (1 ms). The electrical stimulation will be delivered with a&#xD;
      Vectra Genisys System.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Actual">December 31, 2017</completion_date>
  <primary_completion_date type="Actual">December 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Walking Endurance</measure>
    <time_frame>Change from before to after 18 treatment sessions administered over a 6-week period (3 sessions/week).</time_frame>
    <description>Distance walked in 6 min</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Modified Fatigue Impact Scale</measure>
    <time_frame>Change from before to after 18 treatment sessions administered over a 6-week period (3 sessions/week).</time_frame>
    <description>MFIS scores range from 0 to 84 and higher numbers indicating worse fatigue.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maximal Walking Speed</measure>
    <time_frame>Change from before to after 18 treatment sessions administered over a 6-week period (3 sessions/week).</time_frame>
    <description>The time it takes to walk 25 ft</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">29</enrollment>
  <condition>Multiple Sclerosis</condition>
  <arm_group>
    <arm_group_label>Narrow pulse</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Six-week treatment of electrical stimulation applied to the calf muscles with stimulus pulses that last 0.4 ms.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wide pulse</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Six-week treatment of electrical stimulation applied to the calf muscles with stimulus pulses that last 1 ms.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Narrow pulse</intervention_name>
    <description>Participants will be randomly assigned to one of two study arms to receive a 6 week treatment of electrical stimulation that comprises narrow (0.4 ms) stimulus pulses.</description>
    <arm_group_label>Narrow pulse</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Wide pulse</intervention_name>
    <description>Participants will be randomly assigned to one of two study arms to receive a 6 week treatment of electrical stimulation that comprises wide (1 ms) stimulus pulses.</description>
    <arm_group_label>Wide pulse</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Able to read, understand, and speak English to ensure safe participation in the&#xD;
             project&#xD;
&#xD;
          -  Difficulties with walking&#xD;
&#xD;
          -  On stable doses of Ampyra, provigil, or other symptomatic-treating medications&#xD;
&#xD;
          -  No systemic steroids within the last 30 days&#xD;
&#xD;
          -  Not currently exercising more than 2x/wk&#xD;
&#xD;
          -  Able to arrange own transportation to and from the laboratories&#xD;
&#xD;
          -  Provide informed consent, including willingness to be randomly assigned to one of the&#xD;
             two groups&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Documented MS-related relapse in the last 3 months&#xD;
&#xD;
          -  Medical diagnosis or condition that is considered to be an absolute or relative&#xD;
             contraindication to participating in exercise training, such as major renal,&#xD;
             pulmonary, hepatic, cardiac, gastrointestinal, HIV, cancer (other than treated basal&#xD;
             cell cancer), other neurological disorders, or pregnancy&#xD;
&#xD;
          -  Poorly controlled diabetes mellitus or hypertension&#xD;
&#xD;
          -  History of seizure disorders&#xD;
&#xD;
          -  Alcohol dependence or abuse (â‰¥2 drinks/day), or present history (last 6 months) of&#xD;
             drug abuse&#xD;
&#xD;
          -  Inability to attend exercise sessions 3 days per week for 6 weeks&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roger Enoka, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Boulder</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jeffrey Hebert, PhD, PT</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Colorado</name>
      <address>
        <city>Boulder</city>
        <state>Colorado</state>
        <zip>80309</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 16, 2014</study_first_submitted>
  <study_first_submitted_qc>May 28, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 2, 2014</study_first_posted>
  <results_first_submitted>November 19, 2020</results_first_submitted>
  <results_first_submitted_qc>May 6, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">May 7, 2021</results_first_posted>
  <last_update_submitted>May 6, 2021</last_update_submitted>
  <last_update_submitted_qc>May 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Colorado, Boulder</investigator_affiliation>
    <investigator_full_name>Roger Enoka</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Walking</keyword>
  <keyword>Mobility</keyword>
  <keyword>Neuromuscular electrical stimulation</keyword>
  <keyword>Multiple sclerosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>January 12, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/85/NCT02152085/Prot_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Three potential participants did not meet eligibility requirements.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Narrow Pulse</title>
          <description>Six-week treatment of electrical stimulation applied to the calf muscles with stimulus pulses that last 0.4 ms.&#xD;
Narrow pulse: Participants will be randomly assigned to one of two study arms to receive a 6 week treatment of electrical stimulation that comprises narrow (0.4 ms) stimulus pulses.</description>
        </group>
        <group group_id="P2">
          <title>Wide Pulse</title>
          <description>Six-week treatment of electrical stimulation applied to the calf muscles with stimulus pulses that last 1 ms.&#xD;
Wide pulse: Participants will be randomly assigned to one of two study arms to receive a 6 week treatment of electrical stimulation that comprises wide (1 ms) stimulus pulses.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Narrow Pulse</title>
          <description>Six-week treatment of electrical stimulation applied to the calf muscles with stimulus pulses that last 0.4 ms.&#xD;
Narrow pulse: Participants will be randomly assigned to one of two study arms to receive a 6 week treatment of electrical stimulation that comprises narrow (0.4 ms) stimulus pulses.</description>
        </group>
        <group group_id="B2">
          <title>Wide Pulse</title>
          <description>Six-week treatment of electrical stimulation applied to the calf muscles with stimulus pulses that last 1 ms.&#xD;
Wide pulse: Participants will be randomly assigned to one of two study arms to receive a 6 week treatment of electrical stimulation that comprises wide (1 ms) stimulus pulses.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="14"/>
            <count group_id="B2" value="15"/>
            <count group_id="B3" value="29"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54" spread="9"/>
                    <measurement group_id="B2" value="55" spread="5"/>
                    <measurement group_id="B3" value="55" spread="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Walking Endurance</title>
        <description>Distance walked in 6 min</description>
        <time_frame>Change from before to after 18 treatment sessions administered over a 6-week period (3 sessions/week).</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Narrow Pulse</title>
            <description>Six-week treatment of electrical stimulation applied to the calf muscles with stimulus pulses that last 0.4 ms.&#xD;
Narrow pulse: Participants will be randomly assigned to one of two study arms to receive a 6 week treatment of electrical stimulation that comprises narrow (0.4 ms) stimulus pulses.</description>
          </group>
          <group group_id="O2">
            <title>Wide Pulse</title>
            <description>Six-week treatment of electrical stimulation applied to the calf muscles with stimulus pulses that last 1 ms.&#xD;
Wide pulse: Participants will be randomly assigned to one of two study arms to receive a 6 week treatment of electrical stimulation that comprises wide (1 ms) stimulus pulses.</description>
          </group>
        </group_list>
        <measure>
          <title>Walking Endurance</title>
          <description>Distance walked in 6 min</description>
          <units>meters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42" spread="60"/>
                    <measurement group_id="O2" value="25" spread="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Modified Fatigue Impact Scale</title>
        <description>MFIS scores range from 0 to 84 and higher numbers indicating worse fatigue.</description>
        <time_frame>Change from before to after 18 treatment sessions administered over a 6-week period (3 sessions/week).</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Narrow Pulse</title>
            <description>Six-week treatment of electrical stimulation applied to the calf muscles with stimulus pulses that last 0.4 ms.&#xD;
Narrow pulse: Participants will be randomly assigned to one of two study arms to receive a 6 week treatment of electrical stimulation that comprises narrow (0.4 ms) stimulus pulses.</description>
          </group>
          <group group_id="O2">
            <title>Wide Pulse</title>
            <description>Six-week treatment of electrical stimulation applied to the calf muscles with stimulus pulses that last 1 ms.&#xD;
Wide pulse: Participants will be randomly assigned to one of two study arms to receive a 6 week treatment of electrical stimulation that comprises wide (1 ms) stimulus pulses.</description>
          </group>
        </group_list>
        <measure>
          <title>Modified Fatigue Impact Scale</title>
          <description>MFIS scores range from 0 to 84 and higher numbers indicating worse fatigue.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34" spread="17"/>
                    <measurement group_id="O2" value="23" spread="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Maximal Walking Speed</title>
        <description>The time it takes to walk 25 ft</description>
        <time_frame>Change from before to after 18 treatment sessions administered over a 6-week period (3 sessions/week).</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Narrow Pulse</title>
            <description>Six-week treatment of electrical stimulation applied to the calf muscles with stimulus pulses that last 0.4 ms.&#xD;
Narrow pulse: Participants will be randomly assigned to one of two study arms to receive a 6 week treatment of electrical stimulation that comprises narrow (0.4 ms) stimulus pulses.</description>
          </group>
          <group group_id="O2">
            <title>Wide Pulse</title>
            <description>Six-week treatment of electrical stimulation applied to the calf muscles with stimulus pulses that last 1 ms.&#xD;
Wide pulse: Participants will be randomly assigned to one of two study arms to receive a 6 week treatment of electrical stimulation that comprises wide (1 ms) stimulus pulses.</description>
          </group>
        </group_list>
        <measure>
          <title>Maximal Walking Speed</title>
          <description>The time it takes to walk 25 ft</description>
          <units>seconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.92" spread="4.21"/>
                    <measurement group_id="O2" value="0.12" spread="1.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>12 weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Narrow Pulse</title>
          <description>Six-week treatment of electrical stimulation applied to the calf muscles with stimulus pulses that last 0.4 ms.&#xD;
Narrow pulse: Participants will be randomly assigned to one of two study arms to receive a 6 week treatment of electrical stimulation that comprises narrow (0.4 ms) stimulus pulses.</description>
        </group>
        <group group_id="E2">
          <title>Wide Pulse</title>
          <description>Six-week treatment of electrical stimulation applied to the calf muscles with stimulus pulses that last 1 ms.&#xD;
Wide pulse: Participants will be randomly assigned to one of two study arms to receive a 6 week treatment of electrical stimulation that comprises wide (1 ms) stimulus pulses.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Roger Enoka</name_or_title>
      <organization>University of Colorado Boulder</organization>
      <phone>3034927232</phone>
      <email>enoka@colorado.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

